SCHEMBL19080072

SCHEMBL19080072

c1ccc2cc3c(cc2c1)oc1cc2cc(-c4ccc5cc(-c6c7ccccc7c(-c7cccc8ccccc78)c7ccccc67)ccc5c4)ccc2cc13

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSD A5PKW4 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
PIM1 P11309 2/20 0.36
MAPT P10636 2/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
SOS1 Q07889 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079954 0.96 CA12 (0.37) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL19076481 0.95 AHR (0.37) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL17944566 0.95 PSD (0.38) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL22062808 0.95 AHR (0.39) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL17944563 0.95 PIM1 (0.37) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL22062822 0.94 AHR (0.36) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL19076487 0.94 MAOA (0.36) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL19109850 0.94 CASP3 (0.37) PSDALDH1A1HSD17B10KDM4ERAB9A
SCHEMBL19076362 0.93 AHR (0.35) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL22062809 0.92 AHR (0.37) PSDALDH1A1HSD17B10KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 PSD 3401/4885ALDH1A1 237/4885HSD17B10 1720/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 PSD 3401/4885ALDH1A1 237/4885HSD17B10 1720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.